Effect of Symbicort ® on GR in Sputum in COPD

NCT01787097 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Chronic Obstructive Lung Disease

Interventions

DRUG: Symbicort® total dose 400ug/12ug
DRUG: Symbicort® total dose 800ug/24ug
DRUG: Formoterol 24ug
DRUG: BUD total dose 800ug

Sponsor

Imperial College London

Collaborators

[object Object]